MBRX
Moleculin Biotech (MBRX)
$69
About Moleculin Biotech (MBRX)
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe in July 2015 and is headquartered in Houston, TX.
Details
Daily high
$4.78
Daily low
$4.36
Price at open
--
52 Week High
$91.25
52 Week Low
$4.36
Market cap
9.7M
Dividend yield
0.00%
Volume
490
Avg. volume
325,688
P/E ratio
-.08
Moleculin Biotech News
Details
Daily high
$4.78
Daily low
$4.36
Price at open
--
52 Week High
$91.25
52 Week Low
$4.36
Market cap
9.7M
Dividend yield
0.00%
Volume
490
Avg. volume
325,688
P/E ratio
-.08